+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients



Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients



Experimental and Clinical Endocrinology and Diabetes 113(4): 195-198



Sudomotor neuropathy is associated with reduction of plantar sweating and contributes to the pathogenesis of diabetic foot ulcers. The aim of the present study was to evaluate the new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy among type 2 diabetic patients. This study included 104 type 2 diabetic patients (51 men) with a mean age of 64.2+/-5.6 years and a mean diabetes duration of 12.8+/-3.7 years. Peripheral neuropathy was diagnosed by means of the Diabetic Neuropathy Index (DNI). Sudomotor neuropathy was assessed by means of colour change in the indicator test. Peripheral neuropathy was diagnosed in 71 patients (68.3 %). Sudomotor neuropathy was diagnosed in 67 patients (94.4 %) with peripheral neuropathy and in 10 patients (30.3 %) without peripheral neuropathy (p=0.0001). Compared with DNI, sensitivity of the indicator test for diagnosing peripheral neuropathy was 94.4 % and specificity was 69.7 %. Overall prevalence of neuropathy was higher using the indicator test (77 patients, 74.0 %) than using the DNI (71 patients, 68.3 %). Time until complete colour change of the indicator test was 23.8+/-6.7 min in patients with peripheral neuropathy and 7.7+/-1.2 min in patients without peripheral neuropathy (p=0.001). Among patients with peripheral neuropathy, time until complete colour change of the indicator test was 14.2+/-1.9 min in those with a DNI value between 2.5 and 4.5, while it was 32.8+/-2.6 min in those with a DNI value between 5 and 8 (p=0.003). Use of the new indicator test has a very high sensitivity in detection of diabetic peripheral neuropathy. Sudomotor dysfunction can be demonstrated in a considerable part of patients with normal clinical examination. Time until complete colour change of the indicator test is associated with severity of peripheral neuropathy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048993667

Download citation: RISBibTeXText

PMID: 15891953

DOI: 10.1055/s-2005-837735


Related references

A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes 116(2): 135-138, 2008

Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication. Experimental and Clinical Endocrinology and Diabetes 113(10): 577-581, 2005

Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. Journal of Diabetes and its Complications 21(6): 353-358, 2007

Neuropad (R) indicator test for diagnosis of sudomotor dysfunction in type 2 diabetes. Advances in Therapy 24(5): 1020-1027, 2007

A prospective study on the use of the indicator test Neuropad® for the early diagnosis of peripheral neuropathy in type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes 119(2): 122-125, 2011

Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients. Experimental and Clinical Endocrinology & Diabetes 115(1): 58-61, 2007

Neuropad® A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. 2012

The Neuropad test in the screening of peripheral neuropathy in diabetic patients. Acta Medica Portuguesa 22(6): 729-734, 2010

Neuropad test for sudomotor function to predict the risk of diabetic foot ulceration. Nan Fang Yi Ke Da Xue Xue Bao 34(4): 560-562, 2014

The Neuropad test: a visual indicator test for human diabetic neuropathy. Diabetologia 51(6): 1046-1050, 2008

Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation. Diabetes and Metabolism 37(6): 527-532, 2011

Evaluation of sudomotor function in patients with peripheral neuropathy. Neurology 40(4 Suppl. 1): 386, 1990

Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care 31(2): 236-237, 2007

Sudomotor function in diabetic peripheral artery disease: a role for diabetic neuropathy?. Neurological Sciences 39(1): 191-192, 2018

Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey. Diabetes/Metabolism Research and Reviews 28(8): 692-697, 2012